Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001810559 | SCV001474180 | uncertain significance | not provided | 2020-04-13 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001336807 | SCV001530304 | uncertain significance | Elliptocytosis 3 | 2018-08-22 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Gene |
RCV001810559 | SCV002574143 | uncertain significance | not provided | 2022-03-18 | criteria provided, single submitter | clinical testing | Reported heterozygous in a patient in published literature with a clinical suspicion of a hereditary red blood cell defect, but detailed clinical and segregation information were not provided (Andolfo et al., 2021); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34201899) |
Revvity Omics, |
RCV001810559 | SCV003822722 | uncertain significance | not provided | 2022-06-30 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001810559 | SCV004227302 | uncertain significance | not provided | 2022-12-28 | criteria provided, single submitter | clinical testing |